Quality Investor

OptimizeRx Corporation

Rank #109Op. Leverage

OPRX · Nasdaq · Healthcare

OptimizeRx Corporation (OPRX) — Rank #109 by gross profitability (GP/assets 0.45) · ROE 3.9% · Piotroski F-Score 8 / 9.

As-of 2026-09-15 · CIK 0001448431 · all metrics point-in-time as of the filing date.

About

OptimizeRx Corporation operates as a digital healthcare technology company.

Show more

It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.

The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Industry
Health Information Services
Sector
Healthcare
State
NV
Filer Category
Non-accelerated filerSmaller reporting company
Fiscal Year End
December 31

Segments

A revenue-by-segment breakdown is not available for OPRX. This is expected for a single-reportable-segment filer with no product/service revenue disaggregation, or for a company whose filings predate SEC’s XBRL viewer.